Anonymous User
Login / Registration

a hepatologie

Gastroenterology and Hepatology

Gastroent Hepatol 2021; 75(1): 68–71. doi: 10.48095/ccgh202168.

Neuroendocrine tumor of the periappendicular area of the cecum bottom – a case report

Lukáš Bača1, Róbert Psár2,3, Martin Hanousek1, Petr Fojtík1

+ Affiliation


Neuroendocrine tumors are slow-growing neoplasms, histologically based on enteroendocrine cells. They are tumors with different degrees of differentiation, uncertain bio­logical nature and metastatic ability. Their most common localization is the gastrointestinal tract, with a special group of the neuroendocrine tumors of appendix, which are incidentally found after appendectomy. In case report, we would like to present a case of a patient with neuroendocrine tumors of appendix dia­gnosed by colonoscopy.


euroendokrinní nádor, appendix, colonoscopy

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users


1. Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum 1998; 41 (1): 75–80. doi: 10.1007/BF02236899.
2. Unver N, Coban G, Arıcı DS et al. Unusual Histopathological Findings in Appendectomy Specimens: A Retrospective Analysis of 2047 Cases. Int J Surg Pathol 2019; 27 (2): 142–146. doi: 10.1177/1066896918784650.
3. Sandor A, Modlin IM. A retrospective analysis of 1570 appendiceal carcinoids. Am J Gastroenterol 1998; 93 (3): 422–428. doi: 10.1111/j.1572-0241.1998.00422.x.
4. Mullen JT, Savarese DM. Carcinoid tumors of the appendix: a population-based study. J Surg Oncol 2011; 104 (1): 41–44. doi: 10.1002/jso. 21888.
5. Goede AC, Caplin ME, Winslet MC. Carcinoid tumour of the appendix. Br J Surg 2003; 90 (11): 1317–1322. doi: 10.1002/bjs.4375.
6. Pape UF, Niederle B, Costa F et al. ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas). Neuroendocrinology 2016; 103 (2): 144–152. doi: 10.1159/000443165.
7. Dasari A, Shen C, Halperin D et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients with Neuroendocrine Tumors in the United States. JAMA Oncol 2017; 3 (10): 1335–1342. doi: 10.1001/jamaoncol.2017.0589.
8. Maggard MA, O‘Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg 2004; 240 (1): 117–122. doi: 10.1097/01.sla.0000129342.67174.67.
9. Ellis L, Shale MJ, Coleman MP. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol 2010; 105 (12): 2563–2369. doi: 10.1038/ajg. 2010.341.
10. Klimstra DS, Kloppell G, La Rosa S et al. Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours: Digestive System Tumours. 5th ed. Lyon: International Agency for Research on Cancer 2019: 16.
11. Hsu C, Rashid A, Xing Y et al. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol 2013; 107 (2): 136–143. doi: 10.1002/jso.23205.
12. Cai W, Tan Y, Ge W et al. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study. Cancer Med 2018; 7 (6): 2699–2709. doi: 10.1002/cam4.1507.
13. Goede AC, Caplin ME, Winslet MC: Carcinoid tumour of the appendix. Br J Surg 2003; 90 (11): 1317–1322. doi: 10.1002/bjs.4375.
14. Groth SS, Virnig BA, Al-Refaie WB et al. Appendiceal carcinoid tumors: predictors of lymph node metastasis and the impact of right hemicolectomy on survival. J Surg Oncol 2011; 103 (1): 39–45. doi: 10.1002/jso.21764.
15. Stinner B, Rothmund M: Neuroendocrine tumours (carcinoids) of the appendix. Best Pract Res Clin Gastroenterol 2005; 19 (5): 729–738. doi: 10.1016/j.bpg.2005.06.003.
16. Šachlová M. Neuroendokrinní nádory v gastroenterologické praxi. Gastroent Hepatol 2016; 70 (3); 220–225. doi: 10.14735/amgh2016csgh.info04.
17. O’Toole D, Grossman A, Gross D et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: bio­chemical markers. Neuroendocrinology 2009; 90 (2): 194–202. doi: 10.1159/000225948.
18. Pape UF, Perren A, Niederle B et al. ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology 2012; 95 (2): 135–156. doi: 10.1159/000335629.
19. Louthan O. Neuroendokrinní tumory appendixu. Vnitř Lék 2009; 55 (11): 1051–1055.
20. Louthan O. Neuroendokrinní tumory tenkého střeva – jejuna a ilea. Čes a Slov Gastroent a Hepatol 2009; 63 (6): 284–291.
14. Landry CS, Woodall C, Scoggins CR et al. Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg 2008; 143 (7): 664–670. doi: 10.1001/archsurg. 143.7.664.
21. Virgone C, Cecchetto G, Alaggio A et al. Appendiceal neuroendocrine tumours in child- hood: Italian TREP project. J Pediatr Gastroenterol Nutr 2014; 58 (3): 333–338. doi: 10.1097/MPG.0000000000000217.
23. Boudreaux JP, Klimstra DS, Hassan MM et al. The NANETS consensus guideline for the dia­gnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas 2010; 39 (6): 753–766.
24. Kunz PL, Reidy-Lagunes D, Anthony LB et al. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas 2013; 42 (4): 557–577. doi: 10.1097/MPA. 0b013e31828e34a4.

Kreditovaný autodidaktický test